The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
----------
Playtech PLC - FTSE 250-listed gambling software firm - Notes betPARX, Parx Casino’s iGaming and sports betting app, has been relaunched in Pennsylvania and New Jersey. The app is enabled by Playtech’s IMS platform and Player Account Management. ‘This makes betPARX the first operator in both Pennsylvania and New Jersey to launch Playtech’s IMS platform,’ company says. Parx Casino, the largest casino in Pennsylvania, first announced the partnership between betPARX and Playtech in February 2021.
----------
Safestore Holdings PLC - FTSE 250-listed self-storage space provider - Says just under 28% of shareholders vote against director remuneration report at annual general meeting. Chair David Hearn says: ‘Whilst we received strong support for the directors’ remuneration report, it was only at 72%. The board appreciates that the 2017 remuneration policy still continues to divide opinion amongst some shareholders, even though it was voted through in 2017. Following recent shareholder engagement by myself and Ian Krieger as the senior independent director, it is understood that some shareholders who voted against the 2017 remuneration policy at its inception have a policy to vote against all future remuneration reports that reflect the subsequent execution of it. From specific conversations with some of our leading shareholders it is clear that their vote against the remuneration report does not reflect a vote against either the management or the board and that they accept fully that the payouts reflect the outstanding value creation for all shareholders over the past five years which has been a significant benefit to all our stakeholders.’
----------
Aquis Exchange PLC - London-based stock exchange operator and software developer - Will assume the business activities of UBS MTF, the non-displayed matching pool of UBS MTF Ltd, which is a subsidiary of UBS AG, subject to regulatory approval and completion. ‘This transfer forms part of the planned 2022 financial targets for Aquis and is anticipated to have a relatively small positive impact on Aquis results during 2022,’ company says.
----------
Baillie Gifford Shin Nippon PLC - invests for capital growth from small Japanese companies - Ends January 31 with net asset value per share of 175.9 pence, sliding from 231.7p at the same point the year prior. NAV total return negative 24.1% versus benchmark losing 4.3%. Chair Neil Donaldson says: ‘Until the current reporting period, the managers’ stock picking approach, which aims to identify young, entrepreneurial and disruptive Japanese companies, had produced impressive results over several years. This approach pays little attention to the composition of the comparative index when constructing the portfolio and consequently the portfolio differs quite markedly from it. It is therefore not unexpected to have a period when performance is not as hoped and indeed it would be odd for this not to be the case; shareholders should expect periods of underperformance.’
----------
Diaceutics PLC - UK testing laboratories company - Approved by the US Centers for Medicare & Medicaid Services to receive US medical claims data at an increased frequency. ‘The data will be integrated with Diaceutics’ weekly aggregated Lab data within the DXRX diagnostic commercialisation platform, providing enhanced insight into the testing landscape for Precision Medicine,’ company explains. Adds: ‘By increasing the frequency of data feeds, Diaceutics’ pharma and diagnostic clients can understand the evolving testing landscape in near real-time, empowering strategies to drive faster access to the right treatment.’
----------
Genflow Biosciences PLC - London-based biotechnology firm focused on longevity and development of therapies to counteract the effects of ageing - Subsidiary Genflow Biosciences SRL wins a non-dilutive research grant award of up to €3.4 million from the regional government of Wallonia in southern Belgium. Company says: ‘Genflow will use the grant to expedite its planned research and development activity. The substantial grant funding is non-dilutive to Genflow shareholders and is a significant benefit to the Company alongside the relatively low operating costs that Genflow BE benefits from.’
----------
National Milk Records - AQSE-listed Chippenham, England-based agri-tech company, providing information on the production, health and fertility of cattle to the UK dairy industry - Wins exclusive licence for the exploitation of GenoCells technology in the US, which is an extension to an existing exclusive arrangement covering the UK. ‘Using a process called SNP genotyping, GenoCells can detect mastitis and sub-clinical mastitis for genomically tested herds, by reference and analysis of one sample of milk from a bulk-tank, without the need to sample and test the individual animals within the herd,’ company explains.
----------
Alkemy Capital Investments PLC - London-based company focused on acquisition in mining and technology metals sectors - Wholly-owned subsidiary Tees Valley Lithium ‘working rapidly towards’ establishing the UK’s first low-carbon, battery-grade lithium hydroxide processing facility, located in Teesside. Looking to hit ‘key milestone’ of completing the Class 4 Feasibility Study, which will define the base case technical and economic basis for the operation.
----------
Power Metal Resources PLC - London-based metals exploration company focused in North America, Africa and Australia - Finds four high-priority areas at 83%-owned Selta project, in the Northern Territory, Australia, following in-depth review of uranium and rare earth element target areas. Chief Executive Paul Johnson says: ‘We believe the Selta project is located in a tier one mining jurisdiction in an area known to contain world-class deposits such as Arafura Resources’ Nolan’s Bore REE-phosphate-uranium-thorium deposit.’
----------
Bradda Head Lithium Ltd - North America-focused lithium development - Receives conditional permission to begin a drilling programme at its Eureka project in Nevada. Will start a 23-hole drilling programme at Eureka, pending a 30-day bond payment adjudication. Notes previous surface sampling carried out by Bradda geologists identified grades of up to 550 parts per million lithium at Eureka, with this programme designed to test the potential for a shallow clay project at surface, similar to Bradda’s other clay assets in Arizona.
----------
Ascent Resources PLC - onshore Caribbean, Hispanic American and European-focused natural resources company - Expects, at current production levels and assuming an average monthly gas price of €120 per megawatt hour, continuing production from only its PG-10 and PG-11A production wells to generate gross production revenues of €150,000 per month - which is a 50% jump on its previous expectations. ‘Revenues continue to accrue on the JV account whilst the Company continues to discuss the various previously announced disputed JV matters with its JV partner and service provider. However, the Company has now decided to invoice its share of concession production revenues relating to the period from April 2020 to February 2022, which were previously not invoiced pending resolution of the previously announced disputes,’ company adds. Also believes new Slovenian mining law could lead to a significant increase in its damages claim. Notes new law includes further restrictions on hydraulic-stimulation with Slovenia now seeking to prohibit all forms of hydraulic stimulation for the purpose of exploration or exploitation of hydrocarbons.
----------
Copyright 2022 Alliance News Limited. All Rights Reserved.
